ArticleFrontiers in oncology2025
Radiomics features from the peritumoral region can be associated with the epilepsy status of glioblastoma patients.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Identifying radiomics features that help predict whether glioblastoma patients are prone to developing epilepsy may contribute to an improvement of preventive treatment and a better understanding of the underlying pathophysiology. Materials and methods: In this retrospective study, 3-T MRI data of 451 pretreatment glioblastoma patients (mean age: 61.2 ± 11.8 years; 268 men, 183 women) were analyzed. Three hundred thirty-six patients reported no epilepsy, while 115 patients were diagnosed with symptomatic epilepsy. A total of 1,546 radiomics features were extracted from contrast-enhancing tumor, peritumoral regions, and normal-appearing white matter as regions of interest using PyRadiomics. The dataset was initially split into a training (70%) and a validation (30%) cohort. The training cohort was used for feature selection with ElasticNet and model optimization. Various machine learning models, including logistic regression (LR), were used to predict epilepsy status. The models' performances were evaluated with the validation cohort, and the area under the curve of the receiver operating characteristics (AUC) was used as a measure. For identifying relevant features, permutation feature importance was applied. Results: The performance of LR using radiomics features from only a single ROI in the validation cohort was AUC = 0.83 (95% CI: 0.76-0.91) and AUC = 0.77 (95% CI: 0.69-0.85) for the peritumoral and white matter regions, respectively. The most important features in peritumoral regions were shape features, while for the white matter region, higher-order features from FLAIR were most relevant. Conclusion: Radiomics features from peritumoral and normal-appearing white matter can be associated with epilepsy status at diagnosis, suggesting an important role of these regions for the development of epilepsy in glioblastoma patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.